graphic
abstract
highlight
identifi
host
factor
requir
rsv
infect
lack
impair
viral
spread
inhibit
glycoprotein
matur
defici
reduc
infect
virus
requir
furin
proteas
decreas
level
primari
human
airway
epitheli
cell
lower
viral
burden
issu
cell
host
microb
hoffmann
et
al
determin
calcium
pump
requir
viru
spread
loss
reduc
activ
calciumdepend
proteas
transgolgi
network
consequ
hinder
viral
glycoprotein
matur
thu
attract
host
target
viral
infect
human
respiratori
syncyti
viru
rsv
major
pathogen
infect
upper
lower
respiratori
tract
result
signific
morbid
mortal
children
well
immunocompromis
elderli
popul
estim
suggest
year
rsv
lead
million
hospit
least
death
children
year
age
falsey
et
al
hall
et
al
nair
et
al
shay
et
al
despit
ongo
effort
approv
vaccin
rsv
treatment
avail
passiv
immunoprophylaxi
shadman
wald
nebul
ribavirin
smith
et
al
clearli
new
treatment
strategi
need
one
treatment
strategi
therapeut
potenti
target
host
protein
requir
rsv
infect
howev
suitabl
target
protein
must
first
identifi
recent
year
genomewid
knockout
ko
screen
human
haploid
cellsand
recent
crispr
ko
screen
varieti
cellshav
use
identifi
host
factor
requir
sever
virus
differ
famili
eg
arenavirida
bunyavirida
filovirida
flavivirida
orthomyxovirida
parvovirida
carett
et
al
jae
et
al
jae
et
al
marceau
et
al
pillay
et
al
riblett
et
al
savidi
et
al
zhang
et
al
case
gene
essenti
nlink
glycosyl
highli
enrich
screen
like
cellsurfac
sugar
play
import
role
viru
attach
prior
receptor
engag
genomewid
ko
screen
highli
success
identifi
entri
factor
viru
receptor
pillay
carett
host
factor
describ
character
interfer
later
step
viral
life
cycl
viru
matur
egress
moreov
unlik
receptor
often
viru
specif
host
gene
requir
late
stage
viral
life
cycl
might
affect
mani
virus
famili
even
virus
differ
famili
potenti
broad
antivir
impact
identifi
host
factor
may
valu
describ
genomewid
ko
screen
perform
human
haploid
cell
identifi
host
factor
requir
rsv
infect
like
similar
screen
virus
protein
involv
nlink
glycosyl
highli
enrich
howev
also
identifi
calcium
pump
resid
transgolgi
network
tgn
unlik
mani
hit
screen
like
affect
viru
entri
mechanist
studi
suggest
critic
late
stage
viru
life
cycl
inde
show
influenc
proteas
activ
golgi
requir
proper
viral
glycoprotein
process
viru
matur
furthermor
show
addit
rsv
varieti
rna
virus
requir
infect
also
provid
evid
even
partial
reduct
protein
level
neg
affect
viru
spread
taken
togeth
featur
make
promis
target
therapeut
intervent
divers
set
emerg
virus
genomewid
screen
identifi
host
factor
requir
rsv
infect
identifi
host
factor
requir
rsv
infect
potenti
therapeut
target
perform
screen
util
librari
human
haploid
cell
mutagen
retrovir
gene
trap
report
previous
carett
et
al
carett
et
al
jae
et
al
jae
et
al
pillay
et
al
cell
surviv
rsv
challeng
harvest
gene
trap
insert
site
identifi
dna
sequenc
figur
tabl
surviv
cell
show
signific
enrich
disrupt
integr
numer
gene
compar
noninfect
cell
gene
involv
heparan
sulfat
biosynthesi
top
hit
gene
import
vesicl
traffick
protein
matur
within
endoplasm
reticulum
er
golgi
apparatu
figur
similar
gene
recent
identifi
host
factor
screen
dengu
viru
denv
west
nile
viru
wnv
zika
viru
zikv
rift
valley
fever
viru
marceau
et
al
riblett
et
al
savidi
et
al
zhang
et
al
also
identifi
secretori
pathway
calcium
ca
transport
atpas
encod
figur
facilit
ca
mn
uptak
tgn
behn
et
al
lissandron
et
al
micaroni
et
al
tgn
rich
enzym
eg
glycosyland
sulfotransferas
proprotein
convertas
requir
ca
andor
mn
cofactor
kaufman
et
al
oda
vanoevelen
et
al
sinc
previous
report
influenc
viru
infect
chose
investig
role
confirm
import
rsv
infect
took
advantag
crispr
genom
edit
gener
ko
cell
clone
figur
consist
screen
nonessenti
cell
surviv
loss
affect
cell
growth
figur
infect
wildtyp
wt
ko
cell
rsv
high
multipl
infect
moi
monitor
initi
infect
hr
post
infect
hpi
low
moi
monitor
viru
spread
hpi
moder
reduct
frequenc
rsvinfect
cell
hpi
compar
ko
cell
wt
cell
context
strong
posit
select
may
moder
effect
viru
entri
allow
ko
cell
surviv
howev
promin
phenotyp
observ
hpi
ko
cell
show
strike
decreas
viru
spread
phenotyp
observ
lowmoi
condit
like
reflect
need
passag
step
viru
assembl
egress
reduc
b
fishtail
plot
unselect
control
set
rsvselect
set
signific
hit
identifi
rsv
screen
label
name
shown
unselect
rsvselect
set
highlight
enrich
distinct
gene
trap
insert
map
count
take
account
orient
rel
affect
gene
per
gene
percentag
sens
orient
gene
trap
insert
axi
total
number
insert
particular
gene
x
axi
plot
hit
color
indic
involv
differ
pathway
blue
heparan
sulfat
biosynthesi
green
vesicular
traffick
red
golgi
calcium
transport
yellow
miscellan
see
also
tabl
suscept
rsv
infect
defect
viral
spread
rescu
transcomplement
figur
result
suggest
may
play
role
entri
primarili
involv
later
stage
viru
life
cycl
made
similar
observ
human
parainfluenza
viru
measl
viru
mev
fail
spread
ko
cell
figur
mev
glycoproteinmedi
cellcel
fusion
significantli
reduc
figur
sinc
host
factor
affect
viru
spread
studi
date
focus
character
role
viru
spread
abil
transport
ca
critic
viral
spread
nine
proteincod
isoform
isoform
figur
use
predominantli
express
isoform
reconstitut
ko
cell
isoform
rescu
viral
spread
figur
shown
isoform
transport
ca
rapidli
degrad
suggest
abil
transport
ca
might
import
viral
spread
dode
et
al
test
reconstitut
ko
cell
mutat
form
isoform
reduc
ca
bind
abil
fairclough
et
al
found
fail
rescu
viral
spread
figur
confirm
treat
ko
cell
calcimycin
ionophor
promot
ca
flux
across
membran
found
also
rescu
defici
illustr
increas
mev
glycoproteinmedi
syncytia
format
upon
addit
calcimycin
figur
result
suggest
abil
pump
ca
tgn
critic
produc
function
viral
glycoprotein
permit
viru
spread
tgn
contain
proteas
furin
import
matur
viral
glycoprotein
requir
appropri
ph
ca
concentr
activ
vanoevelen
et
al
reduc
ca
tgn
ko
cell
may
therefor
affect
proteas
activ
inde
found
furin
protein
level
decreas
ko
cell
restor
upon
transcomplement
suggest
furin
destabil
reduc
ca
condit
figur
furthermor
treat
wt
cell
proprotein
convertas
inhibitor
inhibit
furin
decrvkrcmk
phenocopi
mev
spread
defect
ko
cell
figur
interestingli
spread
rsv
impair
ko
cell
lovo
cell
devoid
furin
activ
spread
rsv
impair
figur
takahashi
et
al
suggest
addit
furin
util
proprotein
convertas
also
impair
ko
cell
like
furin
known
proprotein
convertas
undergo
seri
orchestr
autoproteolyt
cleavag
step
anderson
et
al
differ
convertas
matur
event
occur
distinct
compart
modul
ph
ca
concentr
vanoevelen
et
al
imbal
ion
concentr
affect
proprotein
stabil
activ
resid
tgn
sole
provid
ca
compart
therefor
loss
may
affect
multipl
proprotein
convertas
tgn
inde
furin
local
tgn
furindepend
virus
fail
spread
ko
cell
contrast
lymphocyt
choriomening
viru
lcmv
util
earli
golgi
proteas
beyer
et
al
unaffect
figur
consist
result
show
lcmv
spread
unimpair
furindefici
lovo
cell
figur
decreas
furin
level
ko
cell
suggest
might
produc
viru
particl
uncleav
glycoprotein
unreconstitut
isoform
low
moi
fusion
impair
test
infect
wt
ko
cell
rsv
collect
supernat
quantifi
viral
rna
qrtpcr
infect
progeni
viru
plaqu
assay
supernat
cell
type
similar
number
viral
rna
copi
supernat
ko
cell
significantli
less
infecti
wt
cell
figur
next
evalu
glycoprotein
conform
particl
releas
wt
ko
cell
infect
requir
cleavag
precursor
f
viral
glycoprotein
mediat
viruscel
membran
fusion
syncytia
paramyxovirus
cleavag
perform
cellular
tgn
proteas
furin
chang
dutch
notabl
found
f
protein
viral
particl
releas
ko
cell
mostli
uncleav
figur
defect
viral
spread
fulli
rescu
ad
trypsin
cell
supernat
viral
infect
figur
result
support
model
absent
unabl
transport
ca
tgn
furin
less
activ
glycoprotein
process
viral
infect
reduc
virus
readili
adapt
environment
chang
aris
escap
mutat
help
understand
viral
protein
target
passag
rsv
ko
cell
select
viru
capabl
spread
unabl
select
resist
rsv
variant
howev
five
passag
two
mutat
appear
f
protein
mutat
locat
within
f
protein
antigen
site
shown
confer
resist
neutral
monoclon
antibodi
coelingh
tierney
identifi
clinic
isol
conjunct
chang
proteolyt
cleavag
site
coelingh
winter
interestingli
mutat
locat
within
furinbind
pocket
posit
directli
adjac
consensu
furin
cleavag
site
figur
respiratori
virus
shown
mutat
f
protein
cleavag
site
alter
recognit
cellular
proteas
bando
et
al
collin
et
al
glickman
et
al
tashiro
et
al
therefor
hypothes
mutat
facilit
spread
defici
cell
either
increas
f
protein
suscept
furin
cleavag
creat
better
substrat
differ
proteas
remacl
et
al
addit
work
requir
determin
whether
alon
suffici
viral
spread
cell
whether
also
play
role
select
viru
abl
effici
spread
ko
cell
although
appear
cytotox
wt
viru
interestingli
cell
infect
virus
observ
alter
fusion
properti
select
variant
hyperfusogen
figur
furthermor
variant
spread
effici
ko
cell
less
fit
wt
viru
primari
human
airway
epitheli
hae
cell
cultur
togeth
indic
high
fit
cost
adapt
figur
partial
reduct
decreas
viral
burden
primari
cell
role
promot
viru
spread
limit
cell
observ
similar
defect
viru
spread
knock
hela
cell
furthermor
defect
dose
depend
appar
even
cell
reduc
express
figur
encourag
c
primari
human
airway
epitheli
hae
cell
cultur
infect
wt
passag
virus
moi
cultur
wash
daili
pb
harvest
releas
viru
subsequ
titer
assay
data
repres
mean
sd
three
independ
experi
statist
analysi
perform
twotail
student
test
signific
shown
p
see
also
figur
result
obtain
primari
fibroblast
patient
haileyhailey
diseas
hhd
haploinsuffici
disord
occur
one
allel
function
hu
et
al
sudbrak
et
al
expect
protein
level
lower
fibroblast
hhd
patient
compar
wt
control
although
furin
protein
level
similar
figur
produc
patientderiv
fibroblast
less
infecti
viru
produc
wt
cell
furthermor
abl
fulli
restor
infect
ad
trypsin
figur
test
whether
transient
suppress
wt
cell
could
also
impair
viru
spread
treat
cell
hae
cell
cultur
morpholino
oligom
morpholino
synthet
molecul
modifi
gene
express
block
translat
splice
efficaci
decreas
protein
abund
demonstr
vitro
vivo
bottcherfriebertshaus
et
al
krahl
et
al
moerdykschauweck
et
al
moulton
moulton
morpholino
design
bind
specif
intronexon
junction
interfer
splice
therefor
reduc
abund
figur
observ
spread
titer
significantli
decreas
cultur
system
figur
true
regardless
whether
cultur
treat
prior
infect
may
import
respect
antivir
therapi
figur
addit
paramyxovirus
mani
virus
requir
furin
tgn
proteas
glycoprotein
process
infect
therefor
set
determin
whether
loss
affect
divers
viral
pathogen
flavivirus
testedyellow
fever
viru
yfv
denv
wnv
zikvrequir
spread
effici
figur
similarli
although
less
affect
flavivirus
togavirus
testedvenezuelan
equin
enceph
viru
veev
ross
river
viru
chikungunya
viru
chikv
also
requir
effici
spread
figur
interestingli
veev
chikv
spread
minor
extent
furindefici
lovo
cell
figur
consist
find
show
along
furin
chikv
use
addit
proprotein
convertas
glycoprotein
process
ozden
et
al
abil
use
addit
proprotein
convertas
may
explain
chikv
togavirus
less
sensit
defici
paramyxoand
flavivirus
virus
test
requir
spread
virus
unaffect
loss
includ
herp
simplex
viru
vesicular
stomat
viru
vsv
bunyamwera
viru
bunv
lcmv
figur
glycoprotein
respons
fusion
possess
featur
vsv
glycoprotein
heldwein
et
al
requir
proteolyt
process
roch
et
al
bunv
lcmv
glycoprotein
cleav
beyer
et
al
vincent
et
al
proteas
within
earli
golgi
present
result
genomewid
ko
screen
wherebi
found
ca
pump
tgn
critic
rsv
infect
besid
affect
viral
entri
defici
major
impact
viral
spread
upon
studi
found
like
rsv
virus
paramyxovirida
flavivirida
togavirida
famili
also
fail
spread
cell
show
absent
unabl
transport
ca
tgn
furin
proteas
level
reduc
viral
glycoprotein
process
impair
newli
gener
viru
particl
less
infecti
like
proteas
tgn
besid
furin
also
neg
affect
defici
inde
found
spread
complet
inhibit
cell
spread
low
level
furindefici
lovo
cell
absenc
furin
might
util
proteas
glycoprotein
cleavag
also
impair
cell
wherea
furindepend
virus
highli
impair
cell
vsv
reli
host
proteas
glycoprotein
process
unaffect
bunv
lcmv
also
unaffect
defici
like
bunv
lcmv
glycoprotein
process
proteas
locat
earli
golgi
earli
golgi
maintain
proper
ca
level
next
show
even
reduc
level
decreas
viral
spread
primari
fibroblast
patient
hhd
skin
disord
caus
haploinsuffici
less
suscept
infect
similarli
primari
hae
cell
cultur
system
cell
treat
morpholino
target
also
less
suscept
along
gain
insight
virushost
biolog
goal
work
identifi
potenti
target
antivir
therapi
regard
sever
attract
qualiti
affect
virus
multipl
famili
enzymat
activ
site
target
smallmolecul
compound
reduc
toler
human
even
partial
loss
activ
suffici
decreas
viral
burden
furthermor
mechan
action
impact
tgn
proteas
suggest
filovirus
ebola
viru
highli
pathogen
avian
influenza
virus
might
also
sensit
defici
acut
viral
infect
like
decreas
viral
spread
could
significantli
improv
diseas
outcom
anoth
attract
qualiti
target
may
impact
viral
entri
found
defici
impair
viral
spread
also
reduc
suscept
rsv
infect
besid
proteas
golgiresid
enzym
glycosyland
sulfotransferas
may
neg
affect
loss
absenc
may
therefor
decreas
glycosyl
matur
cellsurfac
protein
therebi
affect
abil
viral
particl
attach
engag
specif
receptor
work
need
elucid
role
shape
plasma
membran
proteom
target
may
interfer
two
critic
step
viral
life
cycl
viral
glycoprotein
matur
requir
releas
infecti
particl
optim
constel
cellsurfac
determin
effici
viru
bind
entri
asid
viral
infect
like
import
varieti
biolog
set
sinc
control
furin
activ
may
also
role
diseas
furin
import
bacteri
toxin
exampl
requir
cleavag
cellsurfac
furin
eg
anthrax
toxin
clostridium
septicum
atoxin
endosom
furin
eg
pseudomona
exotoxin
shiga
toxin
diphtheria
toxin
activ
pathogen
gordon
et
al
gordon
leppla
molloy
et
al
modul
may
also
benefit
patient
diseas
caus
exacerb
furin
tumor
metastasi
bassi
et
al
alzheim
diseas
bennett
et
al
conclus
result
demonstr
affect
cellular
proteas
tgn
like
golgiresid
enzym
glycosyland
sulfotransferas
well
although
work
need
understand
enzym
influenc
viral
entri
replic
pathogen
excit
area
futur
research
detail
method
provid
onlin
version
paper
includ
follow
franc
rockefel
univers
unit
state
protocol
involv
use
human
tissu
review
exempt
rockefel
univers
institut
review
board
primari
human
normal
airway
tracheobronchi
epitheli
cell
nhbe
sex
male
femal
provid
lonza
walkersvil
md
grown
collagenco
transwel
membran
support
airliquid
interfac
week
yield
welldifferenti
polar
human
airway
epitheli
hae
cultur
cell
use
haploid
screen
togeth
hela
lovo
cell
primari
fibroblast
hae
cultur
hit
valid
function
studi
vero
cell
use
viru
product
viru
titrat
cell
line
test
neg
contamin
mycoplasma
obtain
atcc
except
lentix
cell
cell
authent
gener
viral
stock
follow
virus
previous
describ
zhang
et
al
shabman
et
al
deriv
strain
rrv
chikvgfp
tsetsarkin
et
al
deriv
pchikvlr
gfp
veevgfp
petrakova
et
al
deriv
infecti
clone
gener
provid
margaret
macdonald
rockefel
univers
vsvgfp
dalton
rose
gener
provid
john
rose
yale
lcmv
ngo
et
al
deriv
gener
provid
juan
carlo
de
la
torr
scripp
research
institut
zikv
obtain
cdc
ft
collin
amplifi
cell
titer
plaqu
assay
cell
experi
wnv
chikv
carri
biosafeti
level
contain
complianc
institut
feder
guidelin
fulllength
orf
clone
encod
isoform
sino
biolog
use
gener
isoform
isoform
made
pcr
use
expand
high
fidel
pcr
system
roch
synthes
dna
gblock
idt
encod
relev
c
terminu
isoform
made
use
isoform
intern
primer
downstream
initi
codon
mutat
introduc
isoform
use
quikchang
sitedirect
mutagenesi
kit
agil
construct
clone
sequenc
transfer
lentivir
backbon
via
gateway
clone
system
invitrogen
plasmid
use
lentiviru
product
small
guid
rna
sgrna
crispr
edit
target
sgrna
sgrna
design
use
http
crisprmitedu
clone
subsequ
transfect
subsequ
lentiviru
product
describ
previous
cong
et
al
sanjana
et
al
insert
site
locat
refseq
gene
identifi
refseq
gene
longest
transcript
chosen
overlap
gene
region
opposit
orient
disregard
sinc
orient
bia
unambigu
assign
area
number
disrupt
mutat
ie
sens
transcript
orient
nondisrupt
ie
antisens
transcript
orient
mutat
per
individu
gene
count
gene
significantli
enrich
disrupt
mutat
follow
rsv
exposur
determin
use
binomi
test
correct
multipl
test
use
benjaminihochberg
fals
discoveri
rate
fdr
significantli
enrich
gene
integr
rsv
dataset
ncbi
sra
access
compar
refer
dataset
wildtyp
wt
cell
ncbi
sra
access
dataset
analyz
similarli
gene
alreadi
significantli
enrich
wt
dataset
subtract
identifi
rsv
host
factor
gene
cell
cultur
day
follow
transfect
introduc
crispr
edit
hela
cell
transduc
lentivirus
introduc
crispr
edit
select
day
puromycin
mgml
cell
subsequ
seed
plate
densiti
cellswel
order
gener
singl
cell
clone
well
harbor
singl
clone
test
express
western
blot
describ
genom
dna
cell
clone
extract
use
dneasi
blood
tissu
kit
qiagen
follow
manufactur
instruct
genom
dna
ng
subject
pcr
amplif
use
expand
high
fidel
pcr
system
roch
pair
primer
flank
region
contain
crispr
edit
site
forward
primer
revers
primer
result
pcr
product
resolv
agaros
gel
purifi
use
qiaquick
gel
extract
kit
qiagen
follow
sanger
sequenc
test
viru
infect
viru
spread
cell
seed
plate
variou
densiti
base
growth
rate
size
lovo
cellswel
cellswel
hela
primari
fibroblast
cellswel
cell
wash
optimem
prior
infect
virus
dilut
optimem
indic
moi
cell
inocul
h
c
follow
incub
viral
inoculum
remov
cultur
wash
time
optimem
order
remov
residu
viru
particl
initi
inoculum
cultur
wash
addit
time
hpi
incub
c
durat
experi
supernat
progeni
viru
rsv
harvest
hpi
determin
viral
titer
measur
genom
copi
standard
qrtpcr
briefli
viral
rna
isol
supernat
use
qiaamp
viral
rna
mini
kit
qiagen
follow
cdna
synthesi
use
superscript
iii
firststrand
synthesi
system
invitrogen
cdna
product
amplifi
qpcr
use
sybr
green
pcr
master
mix
appli
biosystem
prime
specif
rsvgfp
forward
revers
forward
ctggattgcag
revers
determin
infecti
titer
harvest
supernat
plaqu
assay
perform
vero
cell
rsv
assay
cell
cell
infect
gfptag
virus
zikv
harvest
variou
time
point
assess
initi
infect
viral
spread
cell
harvest
ml
accumax
cell
dissoci
medium
ebiosci
transfer
block
contain
ml
paraformaldehyd
fixat
solut
cell
pellet
rcf
min
c
resuspend
cold
pb
contain
fb
store
c
fac
analysi
cell
infect
zikv
subsequ
stain
use
monoclon
antibodi
antiflaviviru
group
antigen
millipor
primari
antibodi
secondari
antibodi
sampl
analyz
use
lsrii
flow
cytomet
bd
bioscienc
equip
nm
nm
laser
detect
gfp
yfp
venu
tagrfp
data
analyz
use
flowjo
softwar
tree
star
compens
matrix
cell
infect
bunv
harvest
hpi
determin
cell
viabil
use
celltiterglo
promega
accord
manufactur
instruct
luminesc
measur
use
plate
reader
fluostar
omega
bmg
labtech
infect
perform
mevgfp
chose
dose
result
infect
cell
moi
hpi
syncytia
format
start
wt
cell
hae
cultur
rins
pb
prior
infect
transient
remov
apic
secret
suppli
fresh
basolater
medium
prior
inocul
use
pfu
per
cultur
estim
moi
viru
dilut
pb
inoculum
appli
apic
surfac
hae
h
c
follow
incub
viral
inocula
remov
cultur
wash
time
pb
incub
c
durat
experi
progeni
viru
harvest
indic
time
perform
apic
wash
ml
pb
min
c
wash
collect
store
c
prior
analysi
viral
titer
apic
wash
determin
assay
cell
calcium
ionophor
calcimycin
furin
inhibitor
decrvkrcmk
obtain
cayman
chemic
cell
seed
plate
viral
infect
describ
earlier
compound
decrvkrcmk
display
cytotox
extend
treatment
minim
advers
effect
due
compound
treatment
infect
cell
fast
replic
virus
mev
order
focu
syncytia
format
remov
wash
inoculum
decrvkrcmk
ad
concentr
mm
ca
ionophor
ad
later
infect
hpi
concentr
nm
compound
present
throughout
remaind
infect
ntosyllphenylalanin
chloromethyl
keton
tpck
trypsin
sigma
use
mimic
proteolyt
cleavag
infect
perform
ko
cell
primari
human
fibroblast
cell
seed
plate
viral
infect
describ
earlier
remov
wash
inoculum
imdm
contain
low
serum
concentr
fb
ad
supplement
mgml
tpcktrypsin
kept
remaind
infect
western
blot
use
monoclon
antibodi
abnova
furin
monoclon
antibodi
western
blot
probe
f
protein
perform
monoclon
antibodi
gener
provid
ann
moscona
columbia
univers
determin
f
protein
cleavag
cell
seed
plate
cellswel
infect
follow
day
h
c
viru
inoculum
remov
cell
wash
time
pb
ad
back
medium
order
remov
residu
viru
particl
initi
inoculum
cell
wash
time
pb
hpi
ad
back
medium
supernat
harvest
hpi
viru
particl
concentr
spin
h
rcf
c
viru
pellet
lyse
ld
sampl
buffer
nupag
contain
bmercaptoethanol
heat
min
c
store
c
interfer
transcript
vivomorpholino
order
gene
tool
llc
dilut
distil
water
accord
manufactur
vivomorpholino
target
bind
intronexonjunct
exon
vivomorpholino
standard
control
target
human
betaglobin
intron
mutat
caus
betathalassemia
broadli
use
appropri
neg
control
custom
vivomorpholino
oligo
morpholino
ad
apic
site
hae
cultur
differ
concentr
volum
ml
h
prior
infect
h
post
infect
treatment
replenish
everi
h
durat
experi
hae
cultur
harvest
time
infect
h
treatment
probe
protein
level
western
blot
comparison
cell
seed
plate
receiv
similar
treatment
cultur
medium
supplement
morpholino
h
h
prior
infect
time
infect
h
post
infect
replenish
everi
h
durat
experi
cell
harvest
time
infect
h
treatment
western
blot
probe
statist
analysi
perform
prism
graphpad
softwar
statist
test
use
number
biolog
replic
indic
figur
legend
unless
otherwis
state
two
condit
compar
use
twotail
student
test
statist
signific
defin
p
valu
data
avail
upon
request
lead
contact
author
sequenc
data
rsvselect
set
report
paper
access
ncbi
sequenc
read
archiv
access
number
sra
